SCHRODER INVESTMENT MANAGEMENT GROUP recently filed their 13F report for the third quarter of 2022, which ended on 2022-09-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
The Schroder Investment Management Group can be traced to when Johann Heinrich Schröder became a partner at the firm of his brother, establishing J. Henry Schröder & Co. in 1818. By 1970, the company would have established a presence in Latin America and Asia, bringing Japan’s first foreign loan to the London Market. Baron Bruno Schroder, along with Frank Tiarks, would restructure business operations and considerations aid the company’s growth starting in 1895. In the 1923, as New York emerged as a financial center, Schroder would take advantage of the situation and establish a firm there. In the same decade, J. Henry Schröder & Co. would develop an investment department. By the 1950s, the company would be converted into a private company, renamed Schroders Ltd. The company would then have its IPO and be listed on the London Stock Exchange in 1959. The 1960s and 70s would see the company focus on international expansion, establishing a presence in each of the major financial markets. The rest of the century would be spent growing organically and acquiring companies such as Helbert, Wagg & Co. and Wertheim & Co. Inc. as of 2015, the company manages total assets worth approximately half a trillion dollars, managing for its large client base including charities, pension funds, insurance companies, corporations, local and public authorities, and high net worth individuals. Schroder Investment Management Group has continued to focus on international expansion, now having 37 offices in 27 countries to provide its products and services through. The company has over 3500 employees and generates an annual revenue of over 3 billion dollars, translating to $650 million in net income. Some of Schroder's notable mutual funds include The US Opportunities Fund, US Small and Mid-Cap Opportunities Fund, Global Multi-Cap Equity Fund, International Alpha Fund, and Emerging Markets Multi-Cap Equity Fund.
As of the latest 13F report, the guru’s equity portfolio contained 1196 stocks valued at a total of $59.83Bil. The top holdings were MSFT(4.59%), GOOGL(3.14%), and AAPL(2.54%).
According to GuruFocus data, these were SCHRODER INVESTMENT MANAGEMENT GROUP’s top five trades of the quarter.
Danaher Corp
During the quarter, SCHRODER INVESTMENT MANAGEMENT GROUP bought 1,125,732 shares of NYSE:DHR for a total holding of 1,127,932. The trade had a 0.49% impact on the equity portfolio. During the quarter, the stock traded for an average price of $276.14.
On 11/14/2022, Danaher Corp traded for a price of $269.48 per share and a market cap of $196.76Bil. The stock has returned -10.88% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Danaher Corp has a price-earnings ratio of 29.87, a price-book ratio of 4.34, a price-earnings-to-growth (PEG) ratio of 1.58, a EV-to-Ebitda ratio of 19.99 and a price-sales ratio of 6.37.
The price-to-GF Value ratio is 0.87, earning the stock a GF Value rank of 7.
XPeng Inc
The guru sold out of their 6,905,527-share investment in NYSE:XPEV. Previously, the stock had a 0.34% weight in the equity portfolio. Shares traded for an average price of $21.53 during the quarter.
On 11/14/2022, XPeng Inc traded for a price of $8.825 per share and a market cap of $7.45Bil. The stock has returned -82.06% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, XPeng Inc has a price-book ratio of 1.25, a EV-to-Ebitda ratio of -3.03 and a price-sales ratio of 1.64.
Charles Schwab Corp
During the quarter, SCHRODER INVESTMENT MANAGEMENT GROUP bought 2,416,412 shares of NYSE:SCHW for a total holding of 4,028,053. The trade had a 0.29% impact on the equity portfolio. During the quarter, the stock traded for an average price of $69.43.
On 11/14/2022, Charles Schwab Corp traded for a price of $76.23 per share and a market cap of $142.90Bil. The stock has returned -5.75% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Charles Schwab Corp has a price-earnings ratio of 23.27, a price-book ratio of 5.37, a price-earnings-to-growth (PEG) ratio of 1.08 and a price-sales ratio of 7.28.
The price-to-GF Value ratio is 1.01, earning the stock a GF Value rank of 5.
Edwards Lifesciences Corp
SCHRODER INVESTMENT MANAGEMENT GROUP reduced their investment in NYSE:EW by 1,949,897 shares. The trade had a 0.28% impact on the equity portfolio. During the quarter, the stock traded for an average price of $96.22.
On 11/14/2022, Edwards Lifesciences Corp traded for a price of $75.07 per share and a market cap of $46.17Bil. The stock has returned -35.63% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 10 out of 10.
In terms of valuation, Edwards Lifesciences Corp has a price-earnings ratio of 32.19, a price-book ratio of 7.44, a price-earnings-to-growth (PEG) ratio of 2.40, a EV-to-Ebitda ratio of 22.83 and a price-sales ratio of 8.74.
The price-to-GF Value ratio is 0.72, earning the stock a GF Value rank of 10.
Eli Lilly and Co
During the quarter, SCHRODER INVESTMENT MANAGEMENT GROUP bought 512,160 shares of NYSE:LLY for a total holding of 2,379,250. The trade had a 0.28% impact on the equity portfolio. During the quarter, the stock traded for an average price of $316.83.
On 11/14/2022, Eli Lilly and Co traded for a price of $352.66 per share and a market cap of $331.86Bil. The stock has returned 36.02% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Eli Lilly and Co has a price-earnings ratio of 53.16, a price-book ratio of 32.95, a price-earnings-to-growth (PEG) ratio of 2.75, a EV-to-Ebitda ratio of 40.72 and a price-sales ratio of 10.88.
The price-to-GF Value ratio is 1.41, earning the stock a GF Value rank of 1.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
